-1.07 (-3.04%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
  Price Change Change Percent Stock Price Last Traded
-1.07 -3.04% 34.10 11:22:04
Open Price Low Price High Price Close Price Prev Close
34.95 33.82 35.16 35.17
Bid Price Ask Price Spread News
34.02 34.13 0.11 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,084 77,595 $ 34.42 $ 2,670,994 636,483 25.925 - 50.26
Last Trade Time Type Quantity Stock Price Currency
11:22:04 100 $ 34.10 USD

REGENXBIO Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.44B 42.31M 28.51M $ 35.23M $ -17.20M -2.59 -17.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »


Date Time Source News Article
4/08/202116:17Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting..
3/29/202113:28Edgar (US Regulatory)Sec Staff Action/letter (sec Staff)
3/01/202117:27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
3/01/202117:06Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)
3/01/202116:16Edgar (US Regulatory)Annual Report (10-k)
3/01/202116:11Seeking AlphaRegenxbio EPS misses by $1.13, misses on revenue
3/01/202116:07Edgar (US Regulatory)Current Report Filing (8-k)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RGNX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week34.8635.3733.8234.74329,431-0.76-2.18%
1 Month40.8842.4432.1836.73414,497-6.78-16.59%
3 Months48.3449.6332.1840.92403,725-14.24-29.46%
6 Months29.2250.2626.4040.50444,4734.8816.7%
1 Year33.6050.2625.92537.89400,2210.501.49%
3 Years35.1085.1020.0346.68492,184-1.00-2.85%
5 Years11.5385.107.070140.61399,69122.57195.75%

REGENXBIO Description

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa).
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210412 15:37:27